Pharmacokinetics and Drug-Drug Interaction between Samatasvir, an NS5A Inhibitor, and Co-administered Simeprevir, an NS3/4A Protease Inhibitor, and Low Dose Ritonavir-Boosted TMC647055, a Non-Nucleoside NS5B Inhibitor, in Healthy Volunteers and HCV-Infected Subjects

被引：0

作者：

Zhou, Xiao-Jian ^{[1
]}

Pietropaolo, Keith ^{[1
]}

Frank, Dodie ^{[1
]}

Chen, Jie ^{[1
]}

van Heeswijk, Rolf ^{[2
]}

Sullivan-Bolyai, John ^{[1
]}

Van Remoortere, Pieter ^{[3
]}

Verloes, Rene ^{[2
]}

Mayers, Douglas L. ^{[1
]}

机构：

[1] Idenix Pharmaceut Inc, Cambridge, MA USA

[2] Janssen Infect Dis BVBA, Beerse, Belgium

[3] Janssen Res & Dev, Titusville, NJ USA

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1987

引用

页码：1167A / 1168A

页数：2